Skip to main content
Fig. 3 | Cancer Nanotechnology

Fig. 3

From: Nanotechnology approaches to addressing HER2-positive breast cancer

Fig. 3

(Figure reproduced from Cruz and Kayser (2019))

Evaluation of the active targeting capacity of trastuzumab-functionalized gold nanoparticles. a ICP-MS quantification of OH–PEG–AuNP and Tmab–PEG–AuNP uptake into SKBR-3 cells after 24 h incubation. Uptake data are reported as means ± SD. ***p < 0.001 (Student’s t-test). b TEM micrographs of OH–PEG–AuNPs internalized into SKBR-3 cells. Scale bar 200 nm. c TEM micrographs of Tmab–PEG–AuNPs internalized into SKBR-3 cells. Scale bar: 500 nm

Back to article page